Axim Biotechnologies, Inc. financial data

Symbol
AXIM on OTC
Industry
Pharmaceutical Preparations
Location
6191 Cornerstone Court, E, Suite 114, San Diego, CA
State of incorporation
Nevada
Fiscal year end
December 31
Former names
AXIM INTERNATIONAL INC. (to 8/13/2014)
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.37 % -46.4%
Quick Ratio 0.68 % -35.1%
Debt-to-equity -152 % +9.47%
Return On Assets -105 % +52.9%
Operating Margin -2.5K % +83.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 302M shares +27.1%
Common Stock, Shares, Outstanding 294M shares +29.3%
Entity Public Float 5.34M USD
Common Stock, Value, Issued 29.4K USD +29.3%
Weighted Average Number of Shares Outstanding, Basic 232M shares +35.2%
Weighted Average Number of Shares Outstanding, Diluted 479M shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 92.7K USD +254%
Research and Development Expense 90.6K USD -29.6%
Costs and Expenses 1.41K USD
Operating Income (Loss) -2.31M USD +40.2%
Nonoperating Income (Expense) 3.01M USD +98.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.14M USD +56.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -4.14M USD +56.1%
Earnings Per Share, Basic -0.02 USD/shares +66.7%
Earnings Per Share, Diluted -0.02 USD/shares +66.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.5K USD -86.9%
Inventory, Net 20.1K USD -0.19%
Other Assets, Current 3.01K USD
Assets, Current 20.2K USD -79.2%
Property, Plant and Equipment, Net 118K USD +52.1%
Operating Lease, Right-of-Use Asset 183K USD -32.4%
Assets 3.73M USD -12.2%
Accrued Liabilities, Current 0 USD
Liabilities, Current 6.57M USD -21.4%
Long-term Debt and Lease Obligation 93.8K USD
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD
Liabilities 13.3M USD -5.25%
Retained Earnings (Accumulated Deficit) -74.7M USD -5.86%
Stockholders' Equity Attributable to Parent -9.53M USD +2.21%
Liabilities and Equity 3.73M USD -12.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -253K USD -77.9%
Net Cash Provided by (Used in) Financing Activities 196K USD +32%
Net Cash Provided by (Used in) Investing Activities -2.84K USD
Common Stock, Shares Authorized 1B shares +233%
Common Stock, Shares, Issued 294M shares +29.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.04K USD -93.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 10M USD -6.58%
Depreciation 35.2K USD +8.22%
Payments to Acquire Property, Plant, and Equipment 2.84K USD
Lessee, Operating Lease, Liability, to be Paid 196K USD
Property, Plant and Equipment, Gross 260K USD +41.1%
Operating Lease, Liability, Current 34.4K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 103K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 50K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 43.7K USD
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 65.2M USD +7.14%
Operating Leases, Future Minimum Payments, Due in Two Years 20K USD -66.3%
Amortization of Intangible Assets 98.6K USD 0%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 20K USD -66.3%
Share-based Payment Arrangement, Expense 93.9K USD -89.1%
Operating Leases, Future Minimum Payments Due 20K USD -74.8%
Interest Expense 178K USD -76.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%